Astrana Health (ASTH) Competitors

Astrana Health (NASDAQ:ASTH) and Amentum (NYSE:AMTM) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Is ASTH or AMTM more profitable?

Astrana Health has a net margin of 1.04% compared to Amentum's net margin of 0.41%. Amentum's return on equity of 10.90% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.04%	3.43%	1.87%
Amentum	0.41%	10.90%	4.18%

Do analysts recommend ASTH or AMTM?

Astrana Health currently has a consensus price target of $47.40, indicating a potential upside of 55.70%. Amentum has a consensus price target of $28.55, indicating a potential upside of 23.90%. Given Astrana Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Astrana Health is more favorable than Amentum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Amentum	2 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33

Does the media prefer ASTH or AMTM?

In the previous week, Amentum had 3 more articles in the media than Astrana Health. MarketBeat recorded 8 mentions for Amentum and 5 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.86 beat Amentum's score of 0.83 indicating that Astrana Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amentum	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, ASTH or AMTM?

Astrana Health has higher earnings, but lower revenue than Amentum. Amentum is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$2.03B	0.84	$43.15M	$0.51	59.69
Amentum	$12.68B	0.44	-$82M	$0.39	59.08

Do insiders & institutionals have more ownership in ASTH or AMTM?

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 39.9% of Amentum shares are owned by institutional investors. 8.5% of Astrana Health shares are owned by company insiders. Comparatively, 18.7% of Amentum shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Astrana Health beats Amentum on 9 of the 15 factors compared between the two stocks.